Nostrum Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOSTRUM PHARMS LLC
NOSTRUM PHARMS LLC has three approved drugs.
Drugs and US Patents for Nostrum Pharms Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nostrum Pharms Llc | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 200430-002 | Apr 4, 2023 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Nostrum Pharms Llc | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087400-002 | Jan 11, 1983 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Nostrum Pharms Llc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 076756-002 | Dec 12, 2011 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Nostrum Pharms Llc | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087400-004 | Feb 21, 1985 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Nostrum Pharms Llc | THEOPHYLLINE | theophylline | TABLET, EXTENDED RELEASE;ORAL | 087400-003 | Feb 21, 1985 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

